CommentaryA stimulating new target for cancer immunotherapy
References (16)
- et al.
Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand
Blood
(1999) - et al.
Autologous tumor infiltratingT cells cytotoxic for follicular lymphoma cells can be expanded in vitro
Blood
(1997) - et al.
Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system
Blood
(1993) - et al.
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
Nat Med
(1999) - et al.
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
Nat Med
(1999) - et al.
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
Nat Med
(1999) - et al.
Human non-germinal center B cell interleukin(IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma and IL-10: role of B cells in the maintenance of T cell responses
J Exp Med
(1999) - et al.
Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity
Proc Natl Acad Sci USA
(1995)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1999 Elsevier Ltd. All rights reserved.